Steven Cohen Mannkind Corp Transaction History

Point72 Asset Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$3.91 - $5.45 $55,909 - $77,929	14,299 Added 354.37%	18,334 $75,000
Q2 2023 Aug 14, 2023	SELL	$3.72 - $4.79 $6,963 - $8,966	-1,872 Reduced 31.69%	4,035 $16,000
Q1 2023 May 15, 2023	BUY	$3.95 - $5.63 $23,332 - $33,256	5,907 New	5,907 $24,000

245

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.75B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.